BPC-157

Body Protection Compound-157 (Gastric Pentadecapeptide)

AI explanation

BPC-157 Arginate Explained

BPC-157 Arginate is a peptide—basically a small chain of amino acids, the building blocks your body uses to make proteins—that people take to help their body heal itself faster. Think of it as a repair crew for your tissues. What makes this version special is that it's paired with arginine, which makes it stable enough to swallow as a pill instead of requiring injections. That's a big practical difference if you're not keen on needles.

Here's how it actually works once you take it: When you swallow it, the arginine coating protects the peptide from getting destroyed by your stomach acid as it travels through your digestive system. Once it reaches your small intestine, your body absorbs it. From there, it essentially tells your body to turn on its natural repair systems—specifically by activating growth signals and boosting something called nitric oxide, which improves blood flow to damaged areas. This combination helps your tissues rebuild themselves, which is why people use it for gut healing, joint recovery, and general tissue repair.

The arginine itself adds a bonus layer since it's also a precursor to nitric oxide, so you're getting a one-two punch at improving circulation and healing. It's not a magic fix, but it's essentially giving your body better instructions for fixing what's broken.

Dosage Information

Typical Dose

250-500 mcg

Frequency

1-2 times daily

Morning or evening

Administration

Subcutaneous injection or oral

Half-Life

4–6 hours

estimated

Notes

Can be injected near the site of injury for localized effect. Oral administration is effective for gut-related issues. Cycles typically run 4-12 weeks.

Why this matters

Moderate half-life; twice-daily dosing is standard for sustained tissue repair signaling.

Protocol cycle

4-12 weeks on2-4 weeks off

Dose Calculator

Calculate your draw amount for an insulin syringe (U-100)

Concentration: 2,500 mcg/mL

Sign in to save your reconstitution settings for this peptide

Draw to the

10

unit mark

020406080100

Draw 10 units for your 250mcg dose of BPC-157

This calculator is for educational purposes. Always verify your calculations and consult a healthcare professional.

Where does BPC-157 sit?

See how this peptide compares across all 150 peptides in our database.

Evidence Score

0.14

Clinical trials
0.0035%
Literature
0.1030%
Community
0.0020%
Completeness
0.7515%
1 reviews

Compound Data

BPC-157 structure

Molecular Formula

C62H98N16O22

Molecular Weight

1419.50 g/mol

IUPAC Name

(4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid

PubChem CID

9941957

Potential Side Effects

Nausea (rare)Dizziness (rare)Injection site irritationHeadache (uncommon)
Pep Talk

BPC-157 discussions

Frequently Asked Questions about BPC-157

What is BPC-157?

BPC-157 Arginate is a salt form of BPC-157 created by combining BPC-157 with arginine to produce a more stable compound that is orally bioavailable and does not require refrigeration. While standard BPC-157 acetate salt degrades relatively quickly and is typically administered by injection the arginate form has improved stability and demonstrated efficacy via oral administration in research studies. This development has significant practical implications making BPC-157's benefits accessible without injection for users who prefer oral supplementation.

How does BPC-157 work?

BPC-157 Arginate shares the same core mechanism as BPC-157 — promoting angiogenesis tissue repair and gastrointestinal protection through upregulation of growth hormone receptors VEGF and the nitric oxide system. The arginate salt form improves oral bioavailability by protecting the peptide from gastric acid degradation and improving absorption in the small intestine. The arginine component may provide additional benefits through nitric oxide precursor activity complementing BPC-157's own NO-modulating effects. Studies comparing oral arginate to injectable acetate forms have shown comparable biological activity for gastrointestinal applications though systemic tissue repair effects may be better achieved through injection due to first-pass metabolism considerations.

What is the recommended dosage for BPC-157?

The typical dose is 250-500 mcg. 1-2 times daily. Administration: Subcutaneous injection or oral. Can be injected near the site of injury for localized effect. Oral administration is effective for gut-related issues. Cycles typically run 4-12 weeks.

What are the side effects of BPC-157?

Nausea (rare). Dizziness (rare). Injection site irritation. Headache (uncommon)

What is the BPC-157 cycle protocol?

BPC-157 is typically cycled 4-12 weeks on and 2-4 weeks off.

Questions reflect common community inquiries. This is not medical advice.